Paula’s Choice is a brand that’s known for its active ingredients—especially when it comes to those struggling with breakouts ...

It may have originated in the US, but Black Friday has now become a global sales event across bricks-and-mortar and online ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

SEEN Body Wash provides a beautiful lather for the ultimate spa-like cleanse at home, smells enticing, and doesn’t irritate ...

Best wound healing creams to treat cuts and scrapes - Nourishing ingredients to encourage the healing process and prevent ...

Vaseline is the brand name for petroleum jelly, which is really just a mix of waxes and mineral oils in a jelly, ointment-like texture. It has about a bajillion uses, mainly because of its occlusive ...

The Conconi files first came to light at the end of 1999, six years after Roche had retired following 13 years in the peloton, when Italian newspaper La Repubblica broke the news that police in ...

Avène Tolerance Cleansing Gel is a soap-free cleanser designed specifically ... It's also perfect for travel, doubling as a body wash for convenience. La Roche-Posay Cicaplast Balm B5 A cult favourite ...

La Roche-Posay was the greatest contributor to growth, due to the debut of UVmune400 sun care, and the relaunch of Cicaplast. CeraVe became the No. 1 skincare brand in the world. Vichy reported its ...

Zepzelca, used in combination with Roche’s Tecentriq, outperformed Tecentriq alone when used as a first-line maintenance treatment in ES-SCLC following induction therapy with Tecentriq and chemo ...

Sir Brian Roche has been named as the new public service commissioner, 13 months after Peter Hughes announced his retirement from the role. Sir Brian will begin his new role on 4 November and he will ...

With the regulatory approval for advanced breast cancer, Roche’s inavolisib is a potential challenger to Novartis’ PI3K inhibitor Piqray, which last year generated $505 million in revenue. The FDA on ...